Experts Debate and Discuss Therapeutic Strategies Using CDK4/6 Inhibitors Across Breast Cancer

Gain up-to-date insights and knowledge from experts on the therapeutic use of CDK4/6 inhibitors in breast cancer treatment through slides, podcasts, and webcasts.

Share

Program Content

Activities

Adjuvant HR+/HER2- EBC Therapy
Individualizing the Current Adjuvant Therapy Algorithm for Patients With HR+/HER2- EBC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 06, 2024

Expires: December 05, 2025

HR+/HER2- MBC Therapy
Individualizing Therapy for Patients With HR+/HER2- MBC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 06, 2024

Expires: December 05, 2025

CDK4/6 Inhibitor Related AEs
Managing AEs With CDK4/6 Inhibitors to Promote Adherence and Persistence to Oral Therapy in Your Practice
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 06, 2024

Expires: December 05, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation